Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giacomini

Showing results (291-300 of 378) with videos related to

Pageof 38
Sort By:
Molecular Pharmaceutics|December 28, 2012
Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructuresAmber Dahlin, Ethan Geier, Sophie L Stocker, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 29, 2023
Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modelingJ Porter Hunt, Samuel Dubinsky, Autumn M McKnite, et al.
Journal of Human Genetics|May 17, 2013
Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemiaSook Wah Yee, Joel A Mefford, Natasha Singh, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2009
Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5)Harunobu Tahara, Sook Wah Yee, Thomas J Urban, et al.
Cancer Research|September 5, 2006
Organic cation transporters are determinants of oxaliplatin cytotoxicityShuzhong Zhang, Katherine S Lovejoy, James E Shima, et al.
American Journal of Pharmaceutical Education|July 4, 2026
NIH-funded Institutional Training Programs in Colleges and Schools of PharmacyKathleen M Giacomini, Lawrence Lin, Christopher K Surratt, et al.
Endocrinology|November 26, 2002
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptorsS Derick, L L Cheng, M J Voirol, et al.
Clinical Pharmacology and Therapeutics|July 5, 2007
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokineticsY Shu, C Brown, R A Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effectsLisa R Treviño, Noriko Shimasaki, Wenjian Yang, et al.
Diabetes Care|August 28, 2023
Genome-Wide Association Study Identifies Pharmacogenomic Variants Associated With Metformin Glycemic Response in African American Patients With Type 2 DiabetesBaojun Wu, Sook Wah Yee, Shujie Xiao, et al.
Pageof 38

Showing results (291-300 of 378) with videos related to

Sort By:
Pageof 38
Molecular Pharmaceutics|December 28, 2012
Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructuresAmber Dahlin, Ethan Geier, Sophie L Stocker, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 29, 2023
Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modelingJ Porter Hunt, Samuel Dubinsky, Autumn M McKnite, et al.
Journal of Human Genetics|May 17, 2013
Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemiaSook Wah Yee, Joel A Mefford, Natasha Singh, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2009
Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5)Harunobu Tahara, Sook Wah Yee, Thomas J Urban, et al.
Cancer Research|September 5, 2006
Organic cation transporters are determinants of oxaliplatin cytotoxicityShuzhong Zhang, Katherine S Lovejoy, James E Shima, et al.
American Journal of Pharmaceutical Education|July 4, 2026
NIH-funded Institutional Training Programs in Colleges and Schools of PharmacyKathleen M Giacomini, Lawrence Lin, Christopher K Surratt, et al.
Endocrinology|November 26, 2002
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptorsS Derick, L L Cheng, M J Voirol, et al.
Clinical Pharmacology and Therapeutics|July 5, 2007
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokineticsY Shu, C Brown, R A Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effectsLisa R Treviño, Noriko Shimasaki, Wenjian Yang, et al.
Diabetes Care|August 28, 2023
Genome-Wide Association Study Identifies Pharmacogenomic Variants Associated With Metformin Glycemic Response in African American Patients With Type 2 DiabetesBaojun Wu, Sook Wah Yee, Shujie Xiao, et al.
Pageof 38